Detalhe da pesquisa
1.
Shariant platform: Enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretation.
Am J Hum Genet
; 109(11): 1960-1973, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332611
2.
MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia.
Blood
; 129(13): 1791-1801, 2017 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126925
3.
MUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanism.
J Cell Mol Med
; 22(8): 3887-3898, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29761849
4.
Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1.
Br J Haematol
; 176(6): 929-938, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28107546
5.
Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma.
Blood
; 126(3): 354-62, 2015 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26048911
6.
The genetics of extreme microgeographic adaptation: an integrated approach identifies a major gene underlying leaf trichome divergence in Yellowstone Mimulus guttatus.
Mol Ecol
; 25(22): 5647-5662, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27393073
7.
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions.
Sci Transl Med
; 8(368): 368ra171, 2016 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27928025